Evidence map›Paper›PMID 32530958›Full record

ArticlePloS one2020

Dietary flavonoid fisetin binds human SUMO1 and blocks sumoylation of p53.

Vaithish Velazhahan, Przemyslaw Glaza, Alvaro I Herrera, Om Prakash, Michal Zolkiewski, Brian V Geisbrecht, Kathrin Schrick

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. The C-terminal end of PLIN1 displays structural disorder.Biochemistry and biophysics reports · 2025
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vaithish VelazhahanDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.
Przemyslaw GlazaDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, United States of America.
Alvaro I HerreraDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0002-2108-0957
Om PrakashDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, United States of America.
Michal ZolkiewskiDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, United States of America.
Brian V GeisbrechtDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, United States of America.
Kathrin SchrickDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0001-8006-5944
Kansas State University · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

Flavonoids are plant-derived compounds that occur abundantly in fruits and vegetables and have been shown to possess potent anti-cancer, antioxidant, and anti-inflammatory properties. However, their direct targets and molecular mechanism of action are not well characterized, hampering exploitation of the beneficial properties of flavonoids for drug development. Small ubiquitin-related modifier 1 (SUMO1) is attached to target proteins as part of a post-translational modification system implicated in a myriad of cellular processes from nuclear trafficking to transcriptional regulation. Using a combination of surface plasmon resonance, differential scanning fluorimetry and fluorescence quenching studies, we provide evidence for direct binding of the dietary flavonoid fisetin to human SUMO1. Our NMR chemical shift perturbation analyses reveal that binding to fisetin involves four conserved amino acid residues (L65, F66, E67, M82) previously shown to be important for conjugation of SUMO1 to target proteins. In vitro sumoylation experiments indicate that fisetin blocks sumoylation of tumor suppressor p53, consistent with fisetin negatively affecting post-translational modification and thus the biological activity of p53. A series of differential scanning fluorimetry experiments suggest that high concentrations of fisetin result in destabilization and unfolding of SUMO1, presenting a molecular mechanism by which flavonoid binding affects its activity. Overall, our data establish a novel direct interaction between fisetin and SUMO1, providing a mechanistic explanation for the ability of fisetin to modulate multiple key signaling pathways inside cells.

Indexed as

DietFlavonoidsFlavonolsHumansProtein BindingSaccharomyces cerevisiaeSUMO-1 ProteinSumoylationTumor Suppressor Protein p53fisetinFlavonoidsFlavonolsSUMO-1 ProteinSUMO1 protein, humanTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID32530958
PMCPMC7292393
OpenAlexW3034269277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.